+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Endorphins in septic shock: hemodynamic and endocrine effects of an opiate receptor antagonist and agonist

Endorphins in septic shock: hemodynamic and endocrine effects of an opiate receptor antagonist and agonist

Archives of Surgery 117(8): 1053-1057

The pathophysiological role of endorphins in septic shock was studied in a porcine model. Septic shock was induced by the intravenous infusion of live Escherichia coli. Naloxone hydrochloride, an opiate receptor blocker, given during profound septic shock, increased blood concentrations of glucagon and cyclic adenosine monophosphate (cAMP), while BP and cardiac output increased transiently. Heart rate and hepatic glycogen value decreased, but insulin and cortisol levels remained unchanged. In contrast, exogenous morphine injection produced further reduction of BP, increased pulmonary wedge pressure, and increased substance P, while growth hormone level and cardiac output remained unchanged. Neither hormonal nor hemodynamic changes were noted in saline controls. Thus, the endogenous opiates appear partly responsible for the hemodynamic derangements during septic shock, and naloxone is able to reverse such depression, even though the effects are transient and relatively minor when naloxone is given late in the course of septic shock. Endogenous opiates also affect the hormonal homeostasis in shock, and there are indications that this may be mediated by the adenylate cyclase-cAMP system.

(PDF emailed within 1 workday: $29.90)

Accession: 005359061

Download citation: RISBibTeXText

PMID: 6285853

Related references

The effects of opiate agonist and antagonist on serum prolactin in primates: possible role for endorphins in prolactin regulation. Endocrinology 105(1): 284-289, 1979

Effects of an endorphin antagonist and agonist on hormones and cyclic amp in septic shock. Circulatory Shock 8(2): 188-189, 1981

Reduction in opiate activation after chronic electroconvulsive shock--possible role for endorphins in the behavioral effects of convulsive shock treatment. Neuroscience Letters 19(1): 85-88, 1980

Effect of an opiate antagonist (naloxone) and an agonist/antagonist (nalbuphine) in primate hemorrhagic shock: relationship to catecholamine release. Circulatory Shock 17(4): 313-325, 1985

Conditioned taste aversions to compounds with opiate agonist/antagonist activity at specific opiate receptor subtypes. Society for Neuroscience Abstracts 19(1-3): 1027, 1993

Hemodynamic effects of a new histamine H2 receptor agonist (impromidine) and antagonist (ranitidine). Pharmacological Research Communications 14(7): 605-612, 1982

Effects of angiotensin II type 1 receptor antagonist on rats with septic shock. International Journal of Clinical and Experimental Medicine 8(5): 7867-7871, 2015

Effects of addition of a 2-methyl group to ethyl nipecotates (beta-meperidines) on receptor affinities and opiate agonist/antagonist activities. Journal of Medicinal Chemistry 31(10): 2015-2021, 1988

Opiate antagonist prevents μ- and δ-opiate receptor dimerization to facilitate ability of agonist to control ethanol-altered natural killer cell functions and mammary tumor growth. Journal of Biological Chemistry 287(20): 16734-16747, 2012

The influence of the calcium antagonist nimodipine on hemodynamic respiratory metabolic and endocrine parameters during opiate anesthesia. Der Anaesthesist 36(10): 561-569, 1987

Hemodynamic effects of a new cardioselective beta adreno receptor antagonist with partial agonist activity ici 118587 xamoterol fumarate. European Journal of Clinical Investigation 12(2 PART 2): 48, 1982

Opiate receptor thermodynamics agonist and antagonist binding. European Journal of Pharmacology 108(2): 171-178, 1985

Switching agonist/antagonist properties of opiate alkaloids at the d opioid receptor using mutations based on the structure of the orphanin FQ receptor. The Journal of Biological Chemistry 275(29): 939-45, 2000

Opiate receptor pharmacology: mixed agonist/antagonist narcotics. Contemporary Anesthesia Practice 7: 27-43, 1983

Physical separation of the agonist and antagonist forms of a mu opiate receptor?. Life Sciences 33 Suppl 1: 195-198, 1983